- Home
- BEAM vs TSLX Comparison
BEAM vs TSLX Comparison
Compare BEAM & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- TSLX
- Stock Information
- Founded
- BEAM 2017
- TSLX 2010
- Country
- BEAM United States
- TSLX United States
- Employees
- BEAM N/A
- TSLX N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- TSLX Investment Managers
- Sector
- BEAM Health Care
- TSLX Finance
- Exchange
- BEAM Nasdaq
- TSLX Nasdaq
- Market Cap
- BEAM 1.9B
- TSLX 2.0B
- IPO Year
- BEAM 2020
- TSLX 2014
- Fundamental
- Price
- BEAM $24.41
- TSLX $21.99
- Analyst Decision
- BEAM Buy
- TSLX Strong Buy
- Analyst Count
- BEAM 10
- TSLX 7
- Target Price
- BEAM $47.67
- TSLX $22.07
- AVG Volume (30 Days)
- BEAM 1.2M
- TSLX 286.5K
- Earning Date
- BEAM 02-25-2025
- TSLX 02-13-2025
- Dividend Yield
- BEAM N/A
- TSLX 10.39%
- EPS Growth
- BEAM N/A
- TSLX N/A
- EPS
- BEAM N/A
- TSLX 2.06
- Revenue
- BEAM $349,643,000.00
- TSLX $478,363,000.00
- Revenue This Year
- BEAM N/A
- TSLX $11.12
- Revenue Next Year
- BEAM $14.08
- TSLX N/A
- P/E Ratio
- BEAM N/A
- TSLX $10.69
- Revenue Growth
- BEAM 328.73
- TSLX 14.25
- 52 Week Low
- BEAM $20.84
- TSLX $19.50
- 52 Week High
- BEAM $49.50
- TSLX $22.35
- Technical
- Relative Strength Index (RSI)
- BEAM 42.12
- TSLX 71.59
- Support Level
- BEAM $22.50
- TSLX $20.78
- Resistance Level
- BEAM $28.39
- TSLX $21.34
- Average True Range (ATR)
- BEAM 1.56
- TSLX 0.26
- MACD
- BEAM -0.33
- TSLX 0.07
- Stochastic Oscillator
- BEAM 27.67
- TSLX 88.97
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.